Dr. Rodriguez-Monguio is a health economist and professor in the Department of Clinical Pharmacy at the University of California San Francisco (UCSF). I am also the Director of the Medication Outcomes Center, a premier research center for medication safety, economic evaluation, and outcomes research at UCSF. My research focuses on the application of cutting-edge analytical techniques and innovative approaches to evaluate health outcomes and the economic impact of pharmaceuticals and healthcare interventions. Utilizing electronic medical records and administrative data, my work aims to gain a deeper understanding of the comparative effectiveness, cost-effectiveness, and economic impact of pharmaceutical prescribing practices and drug use. A central theme of my research is the examination of the impact of these factors on patient safety, health outcomes, and the cost of healthcare to enhance data-driven decision-making. The goal of my research is to optimize patient-centered health outcomes and drug safety and to inform the implementation of high-value care treatments and interventions.
Dr. Rodriguez-Monguio is a health economist and professor in the Department of Clinical Pharmacy at the University of California San Francisco (UCSF). I am also the Director of the Medication Outcomes Center, a premier research center for medication safety, economic evaluation, and outcomes research at UCSF. My research focuses on the application of cutting-edge analytical techniques and innovative approaches to evaluate health outcomes and the economic impact of pharmaceuticals and healthcare interventions. Utilizing electronic medical records and administrative data, my work aims to gain a deeper understanding of the comparative effectiveness, cost-effectiveness, and economic impact of pharmaceutical prescribing practices and drug use. A central theme of my research is the examination of the impact of these factors on patient safety, health outcomes, and the cost of healthcare to enhance data-driven decision-making. The goal of my research is to optimize patient-centered health outcomes and drug safety and to inform the implementation of high-value care treatments and interventions.